Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04200209Not ApplicableEnrolling By Invitation

To a Sustainable Quality Policy

Role: collaborator

NCT04886427Unknown

Implementation of a Multidimensional Quality Model

Role: collaborator

NCT04589572Not ApplicableSuspended

Extreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF)

Role: collaborator

NCT04230616Not ApplicableRecruiting

Efficacy and Safety of NAVIO

Role: lead

All 4 trials loaded